Dr. Ming-Shyan Huang, MD, PhD, FCCP, FIAC, is a distinguished professor and medical researcher specializing in internal medicine, with a primary focus on lung cancer, airway diseases, and critical care. He currently serves as the Deputy Minister of E-Da Healthcare Group and a professor at the Department of Internal Medicine, School of Medicine, I-Shou University. With decades of experience in both clinical practice and academic research, Dr. Huang has contributed significantly to medical advancements through his leadership roles and research initiatives. His career spans multiple prestigious institutions, including Kaohsiung Medical University, Tokyo Medical University, and Mayo Clinic, where he gained international exposure and developed expertise in pulmonary medicine. Recognized with multiple outstanding research awards, he has demonstrated excellence in medical research, patient care, and healthcare management. His work has influenced both national and international medical communities, reflecting his commitment to advancing internal medicine. With extensive experience in hospital administration, academic mentorship, and groundbreaking research, Dr. Huang continues to make significant contributions to the field of respiratory medicine. His leadership and expertise place him among the top medical researchers in Taiwan and beyond, making him a strong candidate for prestigious research awards.

Professional Profile

• Scopus Profile

Education

Dr. Ming-Shyan Huang’s educational journey is marked by prestigious degrees and international research training. He earned his Doctor of Medicine (MD) from Kaohsiung Medical University, Taiwan, in 1977, laying the foundation for his career in internal medicine. He further pursued a Doctor of Philosophy (PhD) in Internal Medicine from Tokyo Medical University, Japan, in 1986, where he developed specialized expertise in pulmonary medicine. His academic pursuits extended beyond Taiwan and Japan, as he engaged in advanced research training at globally recognized institutions. From 1987 to 1988, he worked as a visiting researcher at Mayo Clinic in Rochester, Minnesota, USA, gaining valuable experience in clinical research and respiratory medicine. His international exposure continued in 1993–1994 when he undertook a postdoctoral fellowship in the Division on Aging, Department of Medicine, at the University of Arkansas for Medical Sciences, USA. His diverse and rigorous academic training across Taiwan, Japan, and the United States provided him with a comprehensive foundation in internal medicine and critical care research. These educational experiences have equipped him with the necessary knowledge and skills to lead cutting-edge research in pulmonary diseases and contribute to advancements in medical science.

Professional Experience

Dr. Ming-Shyan Huang has held various prestigious academic and administrative positions throughout his career, demonstrating his leadership in medical research and healthcare. Since January 2021, he has served as the Deputy Minister of E-Da Healthcare Group while continuing his role as a professor at the Department of Internal Medicine, I-Shou University. From 2017 to 2020, he was the Vice Superintendent of E-Da Cancer Hospital, where he played a crucial role in managing internal medicine services. Prior to this, he spent several years at Kaohsiung Medical University, where he held multiple leadership roles, including Director of the Division of Geriatrics and Gerontology (2010–2017) and Vice Superintendent of Medicine (2009–2011). His tenure at Kaohsiung Medical University also included serving as Director of the Department of Internal Medicine (2006–2009) and Professor of Internal Medicine (1999–2017). Earlier in his career, he was the Director of the Division of Chest Medicine (1997–2004) and an Associate Professor (1988–1999) at Kaohsiung Medical College Hospital. His extensive professional experience in academia, research, and hospital administration highlights his contributions to internal medicine, particularly in respiratory diseases and critical care.

Research Interests

Dr. Ming-Shyan Huang’s research interests focus on lung cancer, airway disease, and critical care, making significant contributions to respiratory medicine. His work in lung cancer explores innovative diagnostic and therapeutic approaches, aiming to improve early detection and treatment strategies. He is also deeply involved in airway disease research, including chronic obstructive pulmonary disease (COPD) and asthma, investigating novel interventions to enhance patient outcomes. His critical care research examines advanced methods for managing severe respiratory conditions, particularly in intensive care settings. Dr. Huang’s interdisciplinary approach integrates clinical practice with laboratory research, ensuring that his findings translate into practical medical applications. His international research experiences at Mayo Clinic and the University of Arkansas have further enriched his expertise in these areas. Additionally, he collaborates with various institutions to develop new medical protocols and improve healthcare systems. His dedication to pulmonary medicine research has led to numerous publications and advancements in respiratory disease management. With a focus on translational medicine, he continues to bridge the gap between scientific discovery and clinical implementation, contributing to the global medical community.

Research Skills

Dr. Ming-Shyan Huang possesses a diverse set of research skills that have contributed to his success in the field of internal medicine. His expertise includes clinical research methodologies, allowing him to conduct in-depth studies on lung cancer, airway diseases, and critical care. He is proficient in advanced diagnostic techniques, including imaging, biomarker analysis, and pulmonary function testing, which are crucial for early disease detection and treatment evaluation. His experience in statistical data analysis enables him to interpret complex clinical trial results and derive meaningful conclusions. Additionally, he has strong skills in grant writing and securing research funding, which have supported his various medical investigations. His collaborative research approach involves working with multidisciplinary teams across different institutions, facilitating knowledge exchange and innovation. He is also skilled in mentoring young researchers and medical professionals, fostering the next generation of scientists in internal medicine. His ability to integrate laboratory research with clinical applications ensures that his findings have a direct impact on patient care. With a strong foundation in experimental design, data interpretation, and academic publishing, Dr. Huang continues to advance medical research in pulmonary and critical care medicine.

Awards and Honors

Dr. Ming-Shyan Huang has received multiple awards and honors recognizing his contributions to medical research and healthcare. He has been honored with the Outstanding Research Award from Kaohsiung Medical University on three occasions, in 2012, 2013, and 2014, highlighting his sustained excellence in scientific investigations. In 2020, he was awarded the Outstanding Research Award from E-Da Hospital, I-Shou University, further acknowledging his impact on medical advancements. These awards reflect his dedication to improving diagnostic and therapeutic approaches in internal medicine, particularly in lung cancer and airway diseases. His research has been widely recognized within Taiwan and internationally, underscoring his leadership in respiratory medicine. Beyond institutional recognition, his work has contributed to major developments in patient care and medical protocols, benefiting both academic research and clinical practice. His numerous accolades serve as a testament to his commitment to excellence in research and innovation in pulmonary medicine. With a distinguished career spanning multiple decades and institutions, Dr. Huang’s achievements continue to influence the field of internal medicine and set a high standard for medical research.

Conclusion

Dr. Ming-Shyan Huang is an accomplished researcher and medical professional with a profound impact on internal medicine, particularly in lung cancer, airway diseases, and critical care. His extensive academic background, international research experience, and leadership in medical institutions demonstrate his dedication to advancing healthcare and medical science. His numerous awards, including multiple Outstanding Research Awards, highlight his significant contributions to respiratory medicine. His expertise in clinical research, innovative diagnostic techniques, and mentorship of young researchers further establish his reputation as a leader in the field. While his research impact is well-recognized, further details on his high-impact publications and international collaborations could strengthen his profile even more. Overall, his career reflects a commitment to scientific discovery and clinical excellence, making him a strong contender for prestigious research awards. His leadership in academia and hospital administration, combined with his research contributions, positions him as a key figure in pulmonary medicine. Moving forward, continued advancements in translational research and global collaborations will further solidify his influence in internal medicine.

Publication Top Notes

1. Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status

   • Authors: B. Blechter, Batel; C. Hsiung, Chao (Agnes); X. Wang, Xiaoyu; W. Tan, Wen; C. Wang, Chihliang
   • Year: 2025
   • Citations: 0

2. Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters

   • Authors: Y. Hsu, Yuanting; C. Wu, Chaochien; C. Wang, Chinchou; M. Huang, Mingshyan; S. Huang, Shauku
   • Year: 2024
   • Citations: 1

3. CD47-mediated immune evasion in early-stage lung cancer progression

   • Authors: C. Chuang, Chenghao; Y.Y. Zhen, Yen Yi; J.Y. Ma, Juei Yang; Y.C. Chang, Yu Chan; C. Yang, Chihjen
   • Year: 2024
   • Citations: 2

4. Increased serum adipokines are associated with sarcopenia in non-obese women with rheumatoid arthritis

   • Authors: T. Fang, Tzujung; M. Chiu, MinhSi; M. Huang, Mingshyan; Y. Yeh, Yaotsung; J. Yen, Jenghsien
   • Year: 2024
   • Citations: 0

5. A Lactobacillus Combination Ameliorates Lung Inflammation in an Elastase/LPS—induced Mouse Model of Chronic Obstructive Pulmonary Disease

   • Authors: H. Shen, Huanting; Y. Fang, Yiting; W. Tsai, Wanhua; B.Y. Wang, Bing Yen; W. Chang, WenWei
   • Year: 2024
   • Citations: 3

6. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

   • Authors: J. Shi, Jianxin; K. Shiraishi, Kouya; J. Choi, Jiyeon; J. Park, Jaeyong; S. Kweon, Sunseong
   • Year: 2023
   • Citations: 27

7. Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer

   • Authors: C.L. Wang, Chi Liang; K.H. Hsu, Kuo Hsuan; Y. Chang, Yahsuan; Y.H. Tsai, Yiang Huang; G. Chang, Geecheng
   • Year: 2023
   • Citations: 11

8. BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters

   • Authors: Y. Hsu, Yuanting; C. Wu, Chaochien; C. Wang, Chinchou; M. Huang, Mingshyan; S. Huang, Shauku
   • Year: 2023
   • Citations: 3

9. Supportive Care Needs Trajectories in Patients With Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy: A Longitudinal Study

   • Authors: C. Yen, Chunju; H. Hsu, Hsintien; H. Hsieh, Hsiufen; M. Huang, Mingshyan; P. Lin, Peichao
   • Year: 2023
   • Citations: 1